Dolex Fem
- Product NDC
- 55758-326
- 11-digit product format
- 557580326
- Labeler code
- 55758
- Product ID
- 55758-326_4a169436-bb76-aceb-e063-6394a90a557f
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Caffeine, Pyrilamine Maleate
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Pharmadel LLC
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-10-01
- Substance
- ACETAMINOPHEN; CAFFEINE; PYRILAMINE MALEATE
- Active strength
- 500; 60; 15 mg/1; mg/1; mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Methylxanthine [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 55758-326 | 55758-326-02 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 55758-326 | 55758-326-50 | D | Discontinued by firm | 2026-10-23 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 55758-326-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 55758-326-50 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 55758-326-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 55758-326-50 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 55758-326-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 55758-326-50 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 55758-326-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 55758-326-50 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 55758-326-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 55758-326-50 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 55758-326-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 55758-326-50 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 55758-326-50 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 55758-326-02 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 55758-326-50 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 55758-326-02 | ed331223b511… | 672a5bd82f5f… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dolex Fem
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
| CAFFEINE | 60 mg/1 |
| PYRILAMINE MALEATE | 15 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| 3G6A5W338E | Internal UNII lookup |
| R35D29L3ZA | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1597298 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| b1cab10b-19f1-f5d5-e053-2995a90a4d5f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 7dea7767-9f52-b60a-5435-33cb9cc28bae | Product name | 4 | 20250124 |
| 6338270f-96cb-0ecb-6fbb-0a9bc78001f4 | Product name | 7 | 20250116 |
| 0ca83774-3f79-b837-5d6f-c210102f3bc8 | Product name | 6 | 20250114 |
| 41b814f3-0166-1c53-c9ef-a0794c7daf9d | Product name | 3 | 20221110 |
| a590be26-846c-8659-a5a1-fb25907965dc | Product name | 2 | 20221110 |
| 2dc76302-91c0-4c35-ad78-99adfb049c4b | Product name | 1 | 20200603 |
| e6065d4b-5ae1-476f-a40e-f2851cbb5d2b | Product name | 2 | 20180221 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 332e86c3-7875-ca6e-f934-2206d2b31996 | Product name | 1 | 20140508 |
| 56625fcc-aa34-9d30-d0e9-1c1beb37ea21 | Product name | 1 | 20140508 |
| 7dfac40f-a405-cd2e-7c06-3059ec0e1092 | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
| d223c173-c39b-d764-47d4-d671d3088815 | Product name | 1 | 20140508 |
| e01133ad-4dcd-c7f3-454b-2ff569ee160a | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 55758-326-02 | 2025-07-31 | Dolex Fem (Health Pharma) |
| 55758-326-02 | 2025-07-31 | Dolex Fem (HHH) |
| 55758-326-25 | 2025-07-31 | Dolex Fem (Health Pharma) |
| 55758-326-25 | 2025-07-31 | Dolex Fem (HHH) |
| 55758-326-50 | 2025-07-31 | Dolex Fem (Health Pharma) |
| 55758-326-50 | 2025-07-31 | Dolex Fem (HHH) |
| 55758-326-02 | 2025-07-29 | Dolex Fem (Health Pharma) |
| 55758-326-02 | 2025-07-29 | Dolex Fem (HHH) |
| 55758-326-25 | 2025-07-29 | Dolex Fem (Health Pharma) |
| 55758-326-25 | 2025-07-29 | Dolex Fem (HHH) |
| 55758-326-50 | 2025-07-29 | Dolex Fem (Health Pharma) |
| 55758-326-50 | 2025-07-29 | Dolex Fem (HHH) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55758-326-02 | Dolex Fem | 2 in 1 PACKET | TABLET, COATED | 2 | 13 | |
| 55758-326-25 | Dolex Fem | 1 in 1 CARTON | TABLET, COATED | 1 | 13 | |
| 55758-326-25 | Dolex Fem | 24 in 1 BLISTER PACK | TABLET, COATED | 24 | 13 | |
| 55758-326-50 | Dolex Fem | 25 in 1 BOX | TABLET, COATED | 25 | 13 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Childrens Acetaminophen | ACETAMINOPHEN | Bryant Ranch Prepack | bdc466c9-d9ae-4293-b7ea-46fb517661c6 | 2025-04-01 | Warnings | M013 |
| Adult Low Dose Enteric Coated Aspirin | ASPIRIN | Geri-Care Pharmaceutical Corp | e327a52a-0e31-44b7-9823-7f60d070ae52 | 2025-04-01 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Proficient Rx LP | 9af5ccc8-aac0-4339-a9f6-58fdc9b91c57 | 2025-04-01 | Warnings | M013 |
| ASPIRIN 325 MG EC | ASPIRIN | Bryant Ranch Prepack | 9d0449d2-c0c6-4e74-931b-35dc62584028 | 2025-03-31 | Warnings | M013 |
| Aspirin 81 mg | ASPIRIN | Bryant Ranch Prepack | cce1e8bd-63c8-403a-bc32-e6788493f604 | 2025-03-31 | Warnings | M013 |
| Adwe Feverx Acetaminophen Caplets, 500 mg Extra Strength | ACETAMINOPHEN | Aurex Laboratories Limited Liability Company | 948c5826-6f35-484d-bb3f-cecf6a4b5c13 | 2025-03-31 | Warnings | M013 |
| Infants Pain and Fever | ACETAMINOPHEN | WALGREENS | 281a530b-c759-50eb-e063-6394a90abb4f | 2025-03-28 | Warnings | M013 |
| Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | WR Group, Inc. | 8281771c-485c-42a9-9a1c-9a7a4298c5b8 | 2025-03-28 | Warnings | M013 |
| Acetaminophen Regular strength | ACETAMINOPHEN | PD-Rx Pharmaceuticals, Inc. | 4181efc2-d183-410c-b647-233444c57e32 | 2025-03-20 | Warnings | M013 |
| CounterAct Pain | ACETAMINOPHEN | Melaleuca, Inc. | 7faf76b4-7f25-377d-e053-2a91aa0a19d4 | 2025-03-20 | Boxed warning, Warnings | M013 |
| Mejoral | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 0bccf571-fcb9-2dd5-e063-6294a90a5f16 | 2025-03-19 | Warnings | M013 |
| ARTRIFIN 24 CAPLETS | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | e7f15c2b-a730-b54f-e053-2a95a90a3b3e | 2025-03-19 | Warnings | M013 |
| Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | TARGET Corporation | 1fc3806e-a5c4-4a6e-951b-dfbf9f5771f1 | 2025-03-17 | Warnings | M013 |
| Signature Select Effervescent Pain Relief | ASPIRIN | Safeway Inc. | 304fca65-2867-c963-e063-6394a90a183f | 2025-03-14 | Warnings | M013 |
| GOOD REMEDIES Extra Strength Pain Relief PM Caplet | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Strive Pharmaceuticals Inc. | 2d642d8e-c154-a970-e063-6294a90a03bf | 2025-03-14 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | DISCOUNT DRUG MART | 97f78c4a-9d0d-4fe1-8b2b-d5f8ab939ac4 | 2025-03-07 | Warnings | M013 |
| Redicare Non-Aspirin 500mg | REDICARE NON-ASPIRIN, ACETAMINOPHEN 500MG | Redicare LLC | 2f229898-1777-732c-e063-6394a90a76bc | 2025-03-04 | Warnings, Adverse reactions | M013 |
| Major Extra Strength Acetaminophen Liquid | ACETAMINOPHEN | Major Pharmaceuticals | 2f3af4dd-45d5-87b4-e063-6294a90ab3cc | 2025-02-28 | Warnings | M013 |
| LOW DOSE ASPIRIN | ASPIRIN | NCS HealthCare of KY, LLC dba Vangard Labs | ed9a71d6-a56e-416a-bb89-6d41307efc5a | 2025-02-27 | Warnings | M013 |
| Aspirin | ASPIRIN | PD-Rx Pharmaceuticals, Inc. | 77429b7f-78e4-42c0-8679-ae8da1748848 | 2025-02-26 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1597298 | acetaminophen 500 MG / caffeine 60 MG / pyrilamine maleate 15 MG Oral Tablet | PSN | b1cab10b-19f1-f5d5-e053-2995a90a4d5f | 13 |
| 1597298 | acetaminophen 500 MG / caffeine 60 MG / pyrilamine maleate 15 MG Oral Tablet | SCD | b1cab10b-19f1-f5d5-e053-2995a90a4d5f | 13 |
| 1597298 | APAP 500 MG / Caffeine 60 MG / Pyrilamine Maleate 15 MG Oral Tablet | SY | b1cab10b-19f1-f5d5-e053-2995a90a4d5f | 13 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 55758-326-02 | 55758032602 | 2 in 1 PACKET | Historical | |||||
| 55758-326-24 | 55758032624 | 1 BOTTLE in 1 CARTON (55758-326-24) > 24 TABLET, COATED in 1 BOTTLE | 1 bottle | 2020-10-01 | 0000-00-00 | No | No | Current |
| 55758-326-25 | 55758032625 | 1 BLISTER PACK in 1 CARTON (55758-326-25) / 24 TABLET, COATED in 1 BLISTER PACK | 1 blister pack | 2020-10-01 | 0000-00-00 | No | No | Current |
| 55758-326-50 | 55758032650 | 25 in 1 BOX | Historical |